Literature DB >> 16372609

Water-soluble upper GI based on clinical findings is reliable to detect anastomotic leaks after laparoscopic gastric bypass.

V G Katasani1, R R Leeth, D S Tishler, T D Leath, B P Roy, C L Canon, S M Vickers, R H Clements.   

Abstract

Anastomotic leak after laparoscopic Roux-en-Y gastric bypass (LGB) is a major complication that must be recognized and treated early for best results. There is controversy in the literature regarding the reliability of upper GI series (UGI) in diagnosing leaks. LGB was performed in patients meeting NIH criteria for the surgical treatment of morbid obesity. All leaks identified at the time of surgery were repaired with suture and retested. Drains were placed at the surgeon's discretion. Postoperatively, UGI was performed by an experienced radiologist if there was a clinical suspicion of leak. From September 2001 until October 2004, a total of 553 patients (age 40.4 +/- 9.2 years, BMI 48.6 +/- 7.2) underwent LGB at UAB. Seventy-eight per cent (431 of 553) of patients had no clinical evidence suggesting anastomotic leak and were managed expectantly. Twenty-two per cent (122 of 553) of patients met at least one inclusion criteria for leak and underwent UGI. Four of 122 patients (3.2%) had a leak, two from anastomosis and two from the perforation of the stapled end of the Roux limb. No patient returned to the operating room without a positive UGI. High clinical suspicion and selectively performed UGI based on clinical evidence is reliable in detecting leaks.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16372609

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  8 in total

1.  Usefulness of Clinical Signs and Diagnostic Tests for Suspected Leaks in Bariatric Surgery.

Authors:  I Arteaga-González; A Martín-Malagón; J Martín-Pérez; A Carrillo-Pallarés
Journal:  Obes Surg       Date:  2015-09       Impact factor: 4.129

2.  Is routine postoperative gastrografin study needed after laparoscopic sleeve gastrectomy? Experience of 712 cases.

Authors:  M Wahby; A F Salama; A F Elezaby; F Belgrami; M E Abd Ellatif; H F El-Kaffas; M Al-Katary
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

Review 3.  Upper gastrointestinal series after Roux-en-Y gastric bypass for morbid obesity: effectiveness in leakage detection. a systematic review of the literature.

Authors:  Giovanni Quartararo; Enrico Facchiano; Stefano Scaringi; Gadiel Liscia; Marcello Lucchese
Journal:  Obes Surg       Date:  2014-07       Impact factor: 4.129

4.  Back to basics--clinical diagnosis in bariatric surgery. Routine drains and upper GI series are unnecessary.

Authors:  Ramsey M Dallal; Linda Bailey; Nissin Nahmias
Journal:  Surg Endosc       Date:  2007-05-05       Impact factor: 4.584

5.  Routine upper GI series after gastric bypass does not reliably identify anastomotic leaks or predict stricture formation.

Authors:  J T Carter; S Tafreshian; G M Campos; U Tiwari; F Herbella; J P Cello; M G Patti; S J Rogers; A M Posselt
Journal:  Surg Endosc       Date:  2007-05-05       Impact factor: 4.584

6.  The utility of radiological upper gastrointestinal series and clinical indicators in detecting leaks after laparoscopic sleeve gastrectomy: a case-controlled study.

Authors:  Monica Sethi; Melissa Magrath; Eduardo Somoza; Manish Parikh; John Saunders; Aku Ude-Welcome; Bradley Schwack; Marina Kurian; George Fielding; Christine Ren-Fielding
Journal:  Surg Endosc       Date:  2015-09-28       Impact factor: 4.584

7.  The utility of routine postoperative upper GI series following laparoscopic gastric bypass.

Authors:  Asok Doraiswamy; Jason J Rasmussen; Jonathan Pierce; William Fuller; Mohamed R Ali
Journal:  Surg Endosc       Date:  2007-05-19       Impact factor: 4.584

8.  Abnormal findings on routine upper GI series following laparoscopic Roux-en-Y gastric bypass.

Authors:  Raghav Raman; Bhargav Raman; Pavithra Raman; Stanford Rossiter; Myriam J Curet; Robert Mindelzun; John M Morton
Journal:  Obes Surg       Date:  2007-03       Impact factor: 3.479

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.